Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-19
    E.g., 2018-10-19

Archive Search

2 results
11:12 AM, Dec 15, 2016  |  BC Innovations | Product R&D

p53 and Ras: Back from the dead

engineered T cell receptor (TCR) that binds mutant KRAS Preclinical siRNA Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA); Kyowa Hakko Kirin
year to use chemical modifications on antibodies to enable cell entry. Dicerna Pharmaceuticals Inc. and Kyowa Hakko Kirin
New Brunswick, N.J. Kite Pharma Inc. (NASDAQ:KITE), Los Angeles, Calif. Kura Oncology Inc., Glendale, Calif. Kyowa Hakko Kirin
12:00 AM, Nov 19, 2015  |  BC Innovations | Product R&D

A solid move

deals this year. First, it licensed a mammalian cell line from BioWa Inc. , a Kyowa Hakko Kirin
Sweden Cellerant Therapeutics Inc., San Carlos, Calif. Glycotope GmbH, Berlin, Germany Innovagen AB, Lund, Sweden Kyowa Hakko Kirin